If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
383.00    -1.00 (-0.26%)
Bid:
383.70
Ask:
383.90
Spread: 0.20 (0.052%)
Market Cap: £7.87b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Final Results

20 May 2026 07:00

RNS Number : 9971E
Marks and Spencer Group PLC
20 May 2026
 

MARKS AND SPENCER GROUP PLC

 

PRELIMINARY RESULTS FOR THE 52 WEEKS ENDED 28 MARCH 2026

 

Marks and Spencer Group plc (the "Company") announces its Preliminary Results for the 52 weeks ended 28 March 2026, which are available to view at: http://www.rns-pdf.londonstockexchange.com/rns/9971E_1-2026-5-19.pdf.

 

In compliance with UK Listing Rules 6.4.1(R) and 6.4.3(R), the Preliminary Results in unedited full text have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Preliminary Results are also available on the Company's corporate website at corporate.marksandspencer.com.

 

Dividend

The Board is proposing a final dividend of 3.0p per share, taking the full-year dividend to 4.2p per share, subject to shareholder approval at the forthcoming Annual General Meeting. If approved, the final dividend will be payable on 10 July 2026 to shareholders on the register of members as at close of business on 5 June 2026. The ordinary shares will be quoted ex dividend on 4 June 2026. For those shareholders electing to participate in the dividend reinvestment plan, the last date for receipt of a new election is 19 June 2026.

 

For further information, please contact:

 

Investor Relations

Fraser Ramzan: +44 (0) 7554 227 758

Helen Lee: +44 (0) 7880 294 990

 

Media Enquiries:

Corporate Press Office: +44 (0) 20 8718 1919

 

Investor & Analyst presentation and Q&A: 

A pre-recorded investor and analyst presentation will be available on the Marks and Spencer Group plc website here from 7:30am on 20 May 2026.

 

Stuart Machin and Alison Dolan will host a Q&A session at 9:30am on 20 May 2026.

 

For the quickest joining experience, please register prior to attending the call here. After registering, you will be given unique dial in details to join the call.

 

Alternatively, you can use the below details to join the call but please join 5-10 minutes before the start time in order to register your details with the operator.

 

Dial in:  +44 (0) 33 0551 0200

Passcode: Quote M&S FY Analyst when prompted by the operator.

Replay: A recording will be available after the call here.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR SFMEEUEMSELI
Date   Source Headline
28th Mar 20195:03 pmRNSDirector/PDMR Shareholding
1st Mar 20194:44 pmRNSHolding(s) in Company
1st Mar 201911:39 amRNSDirector/PDMR Shareholding
1st Mar 20199:00 amRNSTotal Voting Rights
28th Feb 20195:43 pmRNSHolding(s) in Company
27th Feb 20197:00 amRNSM&S and Ocado announce new Joint Venture
26th Feb 201911:24 amRNSMedia speculation into potential deal with Ocado
25th Feb 20194:12 pmRNSHolding(s) in Company
1st Feb 20199:00 amRNSTotal Voting Rights
16th Jan 20191:07 pmRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNS3rd Quarter Results
7th Jan 20195:29 pmRNSHolding(s) in Company
2nd Jan 201912:00 pmRNSBlock listing Interim Review
2nd Jan 20199:00 amRNSTotal Voting Rights
28th Dec 201811:49 amRNSDirector/PDMR Shareholding
27th Dec 20183:55 pmRNSHolding(s) in Company
18th Dec 20183:13 pmRNSHolding(s) in Company
11th Dec 201811:10 amRNSDirectorate Change
11th Dec 201810:31 amRNSHolding(s) in Company
3rd Dec 20189:00 amRNSTotal Voting Rights
28th Nov 20181:24 pmRNSDirector/PDMR Shareholding
26th Nov 20182:42 pmRNSDirector/PDMR Shareholding
9th Nov 20183:14 pmRNSHolding(s) in Company
7th Nov 201812:27 pmRNSHolding(s) in Company
7th Nov 20187:00 amRNSHalf-year Report
1st Nov 20185:49 pmRNSHolding(s) in Company
30th Oct 20182:47 pmRNSDirector/PDMR Shareholding
24th Oct 20185:03 pmRNSHolding(s) in Company
24th Oct 20183:19 pmRNSHolding(s) in Company
18th Oct 201812:34 pmRNSAppointment of corporate broker
3rd Oct 20183:01 pmRNSDirector/PDMR Shareholding
1st Oct 201810:30 amRNSDirectorate Change
1st Oct 20189:00 amRNSTotal Voting Rights
28th Sep 201810:52 amRNSDirector/PDMR Shareholding
17th Sep 20184:36 pmRNSDirector/PDMR Shareholding
4th Sep 201810:12 amRNSDirector/PDMR Shareholding
3rd Sep 20189:00 amRNSTotal Voting Rights
20th Aug 20185:37 pmRNSDirector/PDMR Shareholding
6th Aug 20185:16 pmRNSDirector/PDMR Shareholding
1st Aug 20189:00 amRNSTotal Voting Rights
31st Jul 20183:58 pmRNSDirector/PDMR Shareholding
30th Jul 20185:30 pmRNSDirector/PDMR Shareholding
30th Jul 201811:18 amRNSDirector/PDMR Shareholding
16th Jul 20183:49 pmRNSDirector/PDMR Shareholding
11th Jul 20184:25 pmRNSDirector/PDMR Shareholding
10th Jul 20185:05 pmRNSResult of AGM
2nd Jul 201810:41 amRNSBlock listing Interim Review
2nd Jul 20189:00 amRNSTotal Voting Rights
29th Jun 20185:19 pmRNSDirector/PDMR Shareholding
25th Jun 201811:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.